Introduction
(+)-Methamphetamine (MA) is widely abused among adolescents (12th grade) and young adults. Annual prevalence rates over the last five years range from 1.5 to 3.2% (Johnston et al., 2008a,b) , half of whom are women.
Infants prenatally exposed to MA (Little et al., 1988) or MA and cocaine are more likely to be born premature, have reduced birth weight, and have intraventricular hemorrhages (Dixon and Bejar, 1989; Oro and Dixon, 1987) . They also show signs of withdrawal on the Finnegan scale (Dixon, 1989) . Flash-evoked visual potentials were abnormal in 78% of prenatally MA-cocaine exposed infants and they exhibited reduced visual recognition memory on the Fagan Test of Infant Intelligence (Struthers and Hansen, 1992) . Reduced creatine and glutamate/glutamine ratios have also been reported using magnetic resonance spectroscopy (Smith et al., 2001) , and reductions in hippocampus and forebrain size were found by volumetric magnetic resonance imaging in prenatally MA-exposed children (Chang et al., 2004) . In a prospective study, prenatally MAexposed infants had reduced birth weight and increased rates of SGA (small for gestational age) (Smith et al., 2006) . Fifty-six percent of the MA abusing women used the drug during the first and second trimesters and 44% used during all trimesters (Smith et al., 2006) . A Thai study confirmed that infants prenatally exposed to MA exhibit reduced birth weight and head circumference, have higher rates of SGA, and show increased agitation, vomiting, and tachypnea compared to a non-exposed group (Chomchai et al., 2004) . The brain develops later and over a longer period of development than most other organs. Brain development begins during embryogenesis and continues through fetogenesis and Rats treated with (+)-methamphetamine (MA) on postnatal days (P) 11-20 exhibit long-term spatial and path integration (Morris water maze (MWM) and Cincinnati water maze (CWM)) learning deficits whereas those treated on P1-10 do not. MA treatment increases corticosterone release in an agedependent U-shaped pattern that corresponds to the stress hyporesponsive period (SHRP; P4-15). Here we tested the hypothesis that the cognitive effects induced by MA are associated with treatment that begins within the SHRP. Three treatment regimens were compared, P1-10, P6-15, and P11-20. One male/female pair/litter received 0, 10, or 25 mg/kg MA/dose (four doses/day at 2 h intervals given s.c. with 19-21 litters/regimen). Locomotor activity and acoustic startle were tested as behaviors not predicted to be associated with the SHRP. Cincinnati and Morris water maze findings were consistent with the hypothesis in that MA-treated animals exposed from P6-15 or P11-20 showed impaired learning compared to those exposed from P1-10; however, on probe trials in the Morris water maze, MAinduced memory impairments were not regimen-specific and were contributed to by all treatment regimens. All MA treatment regimens induced reductions in locomotor activity and acoustic startle facilitation as expected. No differential effect on prepulse trials was seen suggesting no impairment in sensory gating. Cognitive deficits from neonatal MA treatment are associated with the SHRP and may be the product of hypothalamic-pituitary-adrenal (HPA) axis dysregulation during critical periods of brain development.
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